Related Experiment Videos
Modulation of mononuclear phagocyte function by intravenous gamma-globulin
Journal of Immunology (Baltimore, Md. : 1950)
|February 1, 1984
Summary
Intravenous gamma-globulin treatment improves mononuclear phagocyte function in patients with idiopathic thrombocytopenic purpura by altering Fc receptor affinity, not number. This therapy enhances in vivo clearance and reduces in vitro phagocytosis.
Area of Science:
- Immunology
- Hematology
Background:
- Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.
- Intravenous gamma-globulin (IVIG) is a common treatment for ITP, but its precise effects on immune cell function require further elucidation.
Purpose of the Study:
- To investigate the impact of IVIG on mononuclear phagocyte system (MPS) function in patients with ITP.
- To differentiate between changes in Fc receptor number versus affinity in response to IVIG therapy.
Main Methods:
- Assessed in vivo MPS clearance using autologous IgG-sensitized erythrocytes before and after IVIG treatment in 11 ITP patients.
- Evaluated in vitro monocyte function, including rosette formation, Fc receptor binding affinity, and phagocytosis of opsonized erythrocytes.
Main Results:
- IVIG treatment significantly prolonged in vivo clearance of IgG-sensitized erythrocytes in all patients (p < 0.01).
- In vitro studies revealed decreased monocyte rosette formation (p < 0.03) and reduced Fc receptor affinity for IgG oligomers (p < 0.008), without significant changes in receptor number.
- Phagocytic capacity for IgG-sensitized erythrocytes was diminished post-IVIG (p < 0.05).
Conclusions:
- IVIG infusions alter mononuclear phagocyte function in ITP patients, independent of serum components in the infusate.
- The observed changes suggest a modulation of Fc receptor affinity, leading to altered immune cell interactions and clearance mechanisms.